BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talebi Bezmin Abadi A, Yamaoka Y. Helicobacter pylori therapy and clinical perspective. Journal of Global Antimicrobial Resistance 2018;14:111-7. [DOI: 10.1016/j.jgar.2018.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Liang B, Yuan Y, Peng X, Liu X, Hu X, Xing D. Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.1042070] [Reference Citation Analysis]
2 Zhang T, Zhang T, Li C, Zhai X, Huo Q. Complementary and alternative therapies for precancerous lesions of gastric cancer: A protocol for a Bayesian network meta analysis. Medicine (Baltimore) 2021;100:e24249. [PMID: 33466209 DOI: 10.1097/MD.0000000000024249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cerri G, Farina M, Brundu A, Gavini E, Salis A, Dathe W. Antibacterial activity of Zn-loaded Cuban zeolite against Helicobacter pylori in comparison to its Na-loaded and unmodified counterparts. Environ Geochem Health 2021;43:2037-48. [PMID: 33244649 DOI: 10.1007/s10653-020-00781-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shi J, Liu L, Li J, Ma X, Qiu H, Shen T. Efficacy and safety of Zuojin Pill for chronic gastritis: Protocol for a systematic review of randomized controlled trials. Medicine (Baltimore) 2020;99:e21248. [PMID: 32702906 DOI: 10.1097/MD.0000000000021248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Winter C, Hartl S, Kolb D, Leitinger G, Roblegg E. Investigations to Evaluate Gastric Mucoadhesion of an Organic Product to Ameliorate Gastritis. Pharmaceutics 2020;12:E331. [PMID: 32272788 DOI: 10.3390/pharmaceutics12040331] [Reference Citation Analysis]
6 Yoon JY, Cha JM, Hong SS, Kim HK, Kwak MS, Jeon JW, Shin HP. Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore) 2019;98:e16601. [PMID: 31464895 DOI: 10.1097/MD.0000000000016601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
7 Boyanova L, Hadzhiyski P, Kandilarov N, Markovska R, Mitov I. Multidrug resistance in Helicobacter pylori: current state and future directions. Expert Rev Clin Pharmacol. 2019;12:909-915. [PMID: 31424296 DOI: 10.1080/17512433.2019.1654858] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 14.7] [Reference Citation Analysis]
8 Gutiérrez-zamorano C, González-ávila M, Díaz-blas G, Smith CT, González-correa C, García-cancino A. Increased anti-Helicobacter pylori effect of the probiotic Lactobacillus fermentum UCO-979C strain encapsulated in carrageenan evaluated in gastric simulations under fasting conditions. Food Research International 2019;121:812-6. [DOI: 10.1016/j.foodres.2018.12.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Xiong Y, Yang Z, Zhang J, Li J, Chen P, Xiang Y. Panning using a phage-displayed random peptide library to identify peptides that antagonize the Helicobacter pylori ArsS acid-sensing domain. Microb Pathog 2019;135:103614. [PMID: 31255726 DOI: 10.1016/j.micpath.2019.103614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Hassan AM, Shawky MAE, Mohammed AQ, Haridy MA, Eid KA. Simvastatin improves the eradication rate of Helicobacter pylori: upper Egypt experience. Infect Drug Resist 2019;12:1529-34. [PMID: 31239728 DOI: 10.2147/IDR.S202346] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 El-Shouny WA, Ali SS, Hegazy HM, Abd Elnabi MK, Ali A, Sun J. Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori. J Tradit Complement Med 2020;10:366-77. [PMID: 32695654 DOI: 10.1016/j.jtcme.2019.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Schramm VL. Enzymatic Transition States and Drug Design. Chem Rev 2018;118:11194-258. [PMID: 30335982 DOI: 10.1021/acs.chemrev.8b00369] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 10.8] [Reference Citation Analysis]